The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
Stockhead on MSN3d
Island completes dosing in phase 2b arm of mosquito-borne dengue trialIsland Pharmaceuticals has completed subject dosing for the phase 2b therapeutic arm of its phase 2a/b PROTECT clinical trial ...
Hosted on MSN3d
AbViro launches NIH-funded dengue challenge trialThe trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.
A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.
Copyright 2025 The Associated Press. All Rights Reserved. A new poll from The Associated Press-NORC Center for Public Affairs Research looks at what U.S. adults think ...
The treatment was first rejected by Nice in March last year - it said it needed further detail about its effectiveness. It also needed a commercial agreement for the drug, which has a list price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback